Clinical Trial Update: 16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluating 16α-18F-fluor-17β-estradiol PET/CT to visualize estrogen receptor positive liver metastases in breast cancer, across Phase 1 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor Positive Liver Metastases

Drugs mentioned

• 16α-18F-fluor-17β-estradiol (16α-18F-fluor-17β-estradiol)

Snippet

Sponsor: University of Aarhus | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED